DK3760633T3 - Oxazino-quinazolin og oxazino-quinazolinforbindelse, fremgangsmåde til fremstilling deraf og anvendelser deraf - Google Patents
Oxazino-quinazolin og oxazino-quinazolinforbindelse, fremgangsmåde til fremstilling deraf og anvendelser deraf Download PDFInfo
- Publication number
- DK3760633T3 DK3760633T3 DK19764669.8T DK19764669T DK3760633T3 DK 3760633 T3 DK3760633 T3 DK 3760633T3 DK 19764669 T DK19764669 T DK 19764669T DK 3760633 T3 DK3760633 T3 DK 3760633T3
- Authority
- DK
- Denmark
- Prior art keywords
- oxazino
- quinazoline
- manufacture
- compound
- quinazoline compound
- Prior art date
Links
- BOTVSXUMBIVXAN-UHFFFAOYSA-N 7H-pyrimido[4,5-f][2,1]benzoxazine Chemical compound C1=CC2=CN=CN=C2C2=C1NOC=C2 BOTVSXUMBIVXAN-UHFFFAOYSA-N 0.000 title 1
- -1 OXAZINO-QUINAZOLINE COMPOUND Chemical class 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Transplantation (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810182708 | 2018-03-06 | ||
| PCT/CN2019/077028 WO2019170088A1 (zh) | 2018-03-06 | 2019-03-05 | 一种噁嗪并喹唑啉与噁嗪并喹啉类化合物及其制备方法和应用 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3760633T3 true DK3760633T3 (da) | 2022-01-31 |
Family
ID=67846907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19764669.8T DK3760633T3 (da) | 2018-03-06 | 2019-03-05 | Oxazino-quinazolin og oxazino-quinazolinforbindelse, fremgangsmåde til fremstilling deraf og anvendelser deraf |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US11548900B2 (da) |
| EP (1) | EP3760633B1 (da) |
| JP (1) | JP7190755B2 (da) |
| KR (1) | KR102526281B1 (da) |
| CN (1) | CN110229171B (da) |
| AU (1) | AU2019230859B2 (da) |
| CA (1) | CA3093323C (da) |
| DK (1) | DK3760633T3 (da) |
| ES (1) | ES2905985T3 (da) |
| PL (1) | PL3760633T3 (da) |
| SG (1) | SG11202008531RA (da) |
| WO (1) | WO2019170088A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202309022A (zh) | 2021-04-13 | 2023-03-01 | 美商努法倫特公司 | 用於治療具egfr突變之癌症之胺基取代雜環 |
| WO2023081637A1 (en) | 2021-11-02 | 2023-05-11 | Enliven Therapeutics, Inc. | Fused tetracyclic quinazoline derivatives as inhibitors of erbb2 |
| WO2024059558A1 (en) * | 2022-09-13 | 2024-03-21 | Enliven Inc. | Polycyclic quinazolines for inhibition of erbb2 |
| WO2025195327A1 (zh) * | 2024-03-19 | 2025-09-25 | 北京鞍石生物科技股份有限公司 | 螺环/桥环化合物及其制备方法和应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7214690B2 (en) | 2001-02-23 | 2007-05-08 | Ligand Pharmaceuticals Incorporated | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
| CN102382106A (zh) | 2010-08-30 | 2012-03-21 | 黄振华 | 苯胺取代的喹唑啉衍生物 |
| CN103965213A (zh) | 2013-02-02 | 2014-08-06 | 江苏奥赛康药业股份有限公司 | 7,8-二氢-6H-[1,4]噁嗪[3,2-g]喹唑啉类衍生物及其制备方法和用途 |
| CN104530063B (zh) | 2015-01-13 | 2017-01-18 | 北京赛特明强医药科技有限公司 | 喹唑啉并杂环类化合物及其制备方法和作为用于治疗癌症的表皮生长因子受体抑制剂的应用 |
| WO2019170086A1 (zh) | 2018-03-06 | 2019-09-12 | 北京赛特明强医药科技有限公司 | 一种酰基取代的噁嗪并喹唑啉类化合物、制备方法及其应用 |
-
2019
- 2019-03-05 KR KR1020207028033A patent/KR102526281B1/ko active Active
- 2019-03-05 CN CN201910162537.0A patent/CN110229171B/zh active Active
- 2019-03-05 CA CA3093323A patent/CA3093323C/en active Active
- 2019-03-05 SG SG11202008531RA patent/SG11202008531RA/en unknown
- 2019-03-05 EP EP19764669.8A patent/EP3760633B1/en active Active
- 2019-03-05 ES ES19764669T patent/ES2905985T3/es active Active
- 2019-03-05 WO PCT/CN2019/077028 patent/WO2019170088A1/zh not_active Ceased
- 2019-03-05 AU AU2019230859A patent/AU2019230859B2/en active Active
- 2019-03-05 DK DK19764669.8T patent/DK3760633T3/da active
- 2019-03-05 JP JP2020546330A patent/JP7190755B2/ja active Active
- 2019-03-05 US US16/978,158 patent/US11548900B2/en active Active
- 2019-03-05 PL PL19764669T patent/PL3760633T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL3760633T3 (pl) | 2022-04-19 |
| AU2019230859A1 (en) | 2020-10-22 |
| CN110229171A (zh) | 2019-09-13 |
| EP3760633B1 (en) | 2021-12-15 |
| JP2021515768A (ja) | 2021-06-24 |
| CA3093323A1 (en) | 2019-09-12 |
| WO2019170088A1 (zh) | 2019-09-12 |
| SG11202008531RA (en) | 2020-10-29 |
| US20210040114A1 (en) | 2021-02-11 |
| EP3760633A1 (en) | 2021-01-06 |
| AU2019230859B2 (en) | 2021-10-21 |
| EP3760633A4 (en) | 2021-01-06 |
| US11548900B2 (en) | 2023-01-10 |
| KR102526281B1 (ko) | 2023-04-27 |
| ES2905985T3 (es) | 2022-04-12 |
| KR20200127223A (ko) | 2020-11-10 |
| CN110229171B (zh) | 2021-03-12 |
| CA3093323C (en) | 2022-11-29 |
| JP7190755B2 (ja) | 2022-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4516357T3 (da) | Antitumorforbindelse, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| DK4053241T3 (da) | Stabiliserede fluorolefinsammensætninger og fremgangsmåder til fremstilling, lagring og anvendelse deraf | |
| DK3676297T3 (da) | Forbindelser, sammensætninger og fremgangsmåder | |
| DK3524603T3 (da) | Fgfr4-hæmmer, fremgangsmåde til fremstilling deraf og farmaceutisk anvendelse deraf | |
| DK3847818T3 (da) | Videoindkoder, videodekoder og tilsvarende fremgangsmåder | |
| DK3430750T3 (da) | Fremgangsmåde til delvis retransmission | |
| DK3580561T3 (da) | Hla-baserede metoder, sammensætninger og anvendelse heraf | |
| DK3901246T3 (da) | Filamentøse svampebiomåtter, fremgangsmåder til fremstilling og fremgangsmåder til anvendelse deraf | |
| DK3884111T3 (da) | Tp-fri monopæl og fremgangsmåde til dannelse heraf | |
| DK3704227T3 (da) | Sammensætning og fremgangsmåde | |
| DK3653796T3 (da) | Hurtigskifter og hurtigudskiftningssystem, der omfatter en sådan hurtigskifter | |
| EP3584239A4 (en) | COMPOUND CONTAINING O-AMINOHETEROARYL ALCYNYL, PROCESS FOR PREPARATION AND USE | |
| DK4428234T3 (da) | Direkte-til-bibliotek-fremgangsmåder, systemer og sammensætninger | |
| DK4241685T3 (da) | Medicinsk system og fremgangsmåde til fremstilling deraf | |
| DK3424924T3 (da) | Ureaforbindelse, fremgangsmåde til fremstilling deraf og medicinsk anvendelse deraf | |
| DK3612579T3 (da) | Pultrudat, fremstilling og anvendelse heraf | |
| DK3737403T5 (da) | Modificerede adenovira | |
| DK3265123T3 (da) | Antistoffer, anvendelser og fremgangsmåder | |
| DK3750893T3 (da) | Dioxazolinforbindelse, fremgangsmåde til fremstilling deraf og anvendelser deraf | |
| DK3858833T3 (da) | Aminonorbornanderivat, fremgangsmåde til fremstilling heraf og anvendelse heraf | |
| DK3545144T3 (da) | Knudeelementer, kits og fremgangsmåder | |
| DK3121318T3 (da) | Beklædningsgenstand og fremgangsmåde til fremstilling | |
| DK3740641T3 (da) | Isoleringsrude og fremgangsmåde til dens fremstilling. | |
| DK3277742T3 (da) | Fluorescerende siloxanelastomer, fremgangsmåde til fremstilling af denne og anvendelsen | |
| IL286330A (en) | Casing for apparatus, apparatus and method |